Brief Review on Ebola Virus Disease and One Health Approach
Overview
Authors
Affiliations
Ebola virus disease (EVD) is a severe and highly fatal zoonotic disease caused by viruses in the family and genus . The disease first appeared in Zaire near the Ebola River in 1976, now in the Democratic Republic of the Congo. Since then, several outbreaks have been reported in different parts of the world, mainly in Africa, leading to the identification of six distinct viral strains that cause disease in humans and other primates. Bats are assumed to be the main reservoir hosts of the virus, and the initial incidence of human epidemics invariably follows exposure to infected forest animals through contact or consumption of bush meat and body fluids of forest animals harboring the disease. Human-to-human transmission occurs when contaminated body fluids, utensils, and equipment come in contact with broken or abraded skin and mucous membranes. EVD is characterized by sudden onset of 'flu-like' symptoms (fever, myalgia, chills), vomiting and diarrhea, then disease rapidly evolves into a severe state with a rapid clinical decline which may lead potential hemorrhagic complications and multiple organ failure. Effective EVD prevention, detection, and response necessitate strong coordination across the animal, human, and environmental health sectors, as well as well-defined roles and responsibilities evidencing the significance of one health approach; the natural history, epidemiology, pathogenesis, and diagnostic procedures of the Ebola virus, as well as prevention and control efforts in light of one health approach, are discussed in this article.
Viruses Identified in Shrews () and Their Biomedical Significance.
Gong H, Chen R, Tan S, Wang X, Chen J, Zhang Y Viruses. 2024; 16(9).
PMID: 39339918 PMC: 11437491. DOI: 10.3390/v16091441.
National burden of Ebola virus disease in Democratic Republic of the Congo: the urgency to act.
Ahmad B, Sagide M, Ntamwinja S, Byiringiro E, Kihanduka E, Rugendabanga E Ann Med Surg (Lond). 2024; 86(8):4579-4585.
PMID: 39118744 PMC: 11305799. DOI: 10.1097/MS9.0000000000002213.
Recent Advances in Therapeutic Approaches Against Ebola Virus Infection.
Soni M, Tulsian K, Barot P, Vyas V Recent Adv Antiinfect Drug Discov. 2024; 19(4):276-299.
PMID: 38279760 DOI: 10.2174/0127724344267452231206061944.
Guttieres D, Diepvens C, Decouttere C, Vandaele N Vaccines (Basel). 2024; 12(1).
PMID: 38250837 PMC: 10819028. DOI: 10.3390/vaccines12010024.